SCHEDULE: OraSure Technologies and Altai Capital Forge Cooperation Agreement

OraSure Technologies and Altai Capital Management have entered into a cooperation agreement, leading to Altai Capital withdrawing its director nominations and agreeing to support the declassification of OraSure's board.

Summary

• Altai Capital Management, L.P. and its affiliates (collectively, the "Reporting Persons") have entered into a Cooperation Agreement with OraSure Technologies, Inc. (the "Issuer").
• Under the agreement, OraSure has committed to appoint John Bertrand to its Board of Directors for a term expiring at the 2026 Annual Meeting.
• OraSure will also nominate and recommend Mr. Bertrand for election at the 2026 Annual Meeting.
• The Board of Directors will seek stockholder approval to declassify the Board at the 2026 Annual Meeting.
• The Reporting Persons will have quarterly opportunities to meet with OraSure's management and the Board to discuss financial and strategic matters.
• In connection with the agreement, Osprey (an affiliate of the Reporting Persons) has withdrawn its intention to nominate Rishi Bajaj and John Bertrand for election to the Board and to present a Declassification Proposal at the 2026 Annual Meeting.
• The agreement includes customary voting commitments and standstill provisions, with restrictions on the Reporting Persons acquiring more than 9.9% of the Issuer's outstanding shares.
• The Cooperation Agreement terminates on the earlier of 30 days prior to the nomination deadline for the 2027 Annual Meeting or March 31, 2027.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, indicating a resolution to potential shareholder activism and a move towards improved corporate governance, though the long-term impact on financial performance is yet to be determined.

Positives

• Resolution of proxy contest through a cooperation agreement, indicating a constructive dialogue between the company and a significant shareholder.
• Appointment of a new director, John Bertrand, to the Board, potentially bringing fresh perspectives.
• Commitment to declassify the Board, which is often viewed positively by investors as it leads to annual accountability for all directors.
• Establishment of a framework for regular engagement between Altai Capital and OraSure's management and Board.
• Withdrawal of director nominations and proposals by Altai Capital, reducing immediate uncertainty and potential disruption.

Negatives

• The need for a cooperation agreement suggests prior disagreements or a proxy contest, which can be a distraction for management and shareholders.
• The standstill provisions, while customary, limit Altai Capital's ability to increase its stake beyond 9.9%.

Risks

• The effectiveness of the new director and the declassification proposal in improving company performance remains to be seen.
• Potential for future disagreements if the cooperation outlined in the agreement does not yield desired results.
• The agreement's termination in March 2027 or prior to the 2027 nomination deadline could lead to renewed activism if issues are not resolved.

Future Outlook

The filing indicates that the Issuer will seek stockholder approval at the 2026 Annual Meeting to amend its charter to declassify the Board. John Bertrand is to be appointed to the Board for a term expiring at this meeting. The Reporting Persons will have quarterly opportunities to engage with management and the Board on financial and strategic matters.

Management Comments

• The Issuer agreed, among other things, to take all necessary actions to appoint John Bertrand to the Board for a term expiring at the Issuer's 2026 Annual Meeting of Stockholders, and to nominate and recommend in favor of Mr. Bertrand's election to the Board at the 2026 Annual Meeting.
• The Cooperation Agreement also includes a commitment by the Board to seek stockholder approval at the 2026 Annual Meeting of an amendment to the Issuer's charter to declassify the Board.
• Pursuant to the Cooperation Agreement, the Reporting Persons will have the opportunity once per quarter to (i) meet with the Issuer's management to discuss financial and strategic matters and (ii) meet with the full Board, or a majority of the Board with the Chief Executive Officer and Chief Financial Officer participating, to share its perspectives.

Industry Context

StockSavvy.ai notes that this filing reflects a common outcome in activist investor campaigns where a resolution is reached through board representation and governance changes, such as board declassification, rather than a prolonged proxy fight. This approach aims to align the interests of activist shareholders with management and the broader shareholder base.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for improved governance and director accountability through board declassification and new director appointment. Reduced risk of disruptive proxy contest.
• Management: Will engage in quarterly discussions with Altai Capital, potentially influencing strategic and financial decisions.
• Board of Directors: Will include a new member and will seek approval for declassification, impacting future board composition and election processes.

Next Steps

• John Bertrand to be appointed to the Board of Directors.
• Nomination and recommendation of John Bertrand for election at the 2026 Annual Meeting.
• Seeking stockholder approval at the 2026 Annual Meeting to declassify the Board.
• Quarterly meetings between Reporting Persons and Issuer's management/Board.
• Cooperation Agreement termination by March 31, 2027, or prior to the 2027 nomination deadline.

Key Dates

Recommendation

The resolution of potential activism through a cooperation agreement and a commitment to board declassification is a positive step for corporate governance. However, the filing does not provide new financial performance data or specific strategic initiatives that would warrant a stronger recommendation. Investors should monitor the impact of the new director and the declassification on future performance.

Keywords

OraSure Technologies, Altai Capital Management, Schedule 13D, Cooperation Agreement, Board of Directors, Director Nomination, Declassification, Corporate Governance, Activist Investor